1. <th id="6zpul"><option id="6zpul"><acronym id="6zpul"></acronym></option></th><u id="6zpul"></u>

    2. <code id="6zpul"><video id="6zpul"></video></code>
      <pre id="6zpul"><nobr id="6zpul"></nobr></pre>

      <code id="6zpul"></code>

      <dfn id="6zpul"><sup id="6zpul"></sup></dfn>

      <object id="6zpul"></object>
    3. <code id="6zpul"></code>
    4. 2010年1月至今,引用Selleck產品的頂級學術期刊文獻已達 431 篇!

      已有十四位諾貝爾獎得主使用Selleck產品發表文獻45篇!

      THE NOBEL PRIZE

      THE NOBEL PRIZE

      David Julius

      2021年獲得諾貝爾生理學或醫學獎

      Michael Houghton

      2020年獲得諾貝爾生理學或醫學獎

      James P. Allison

      2018年獲得諾貝爾生理學或醫學獎

      Michael Rosbash

      2017年獲得諾貝爾生理學或醫學獎

      Eric Richard Kandel

      2000年獲得諾貝爾生理學或醫學獎

      Robert Lefkowitz

      2012年獲得諾貝爾化學獎

      Aaron Ciechanover

      2004年獲得諾貝爾化學獎

      新產品

      目錄號 產品名 Target Pathway 產品描述
      S8944 G150 Others Others G150 is a potent and highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with IC50 of 10.2 nM.
      S8913 TH5487 Others Others TH5487 is a selective active-site inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1) with IC50 of 342 nM.
      S8938 KGA-2727 SGLT GPCR & G Protein KGA-2727 is a potent, selective, high-affinity inhibitor of sodium glucose cotransporter 1 (SGLT1) with Ki of 97.4 nM and 43.5 nM for human SGLT1 and rat SGLT1, respectively. The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat). KGA-2727 exhibits antidiabetic efficacy in rodent models.
      S8939 Mizagliflozin SGLT GPCR & G Protein Mizagliflozin is a novel, potent, selective sodium glucose co-transporter 1 (SGLT1) inhibitor with Ki of 27 nM for human SGLT1. The selectivity ratio (Ki value for human SGLT2/Ki value for human SGLT1) of mizagliflozin is 303. Mizagliflozin shows the potential use for the amelioration of chronic constipation.
      S7013 Guadecitabine (SGI-110) Others Others Guadecitabine (SGI-110) is a next-generation hypomethylating agent whose active metabolite decitabine has a longer in-vivo exposure time than intravenous decitabine.
      S8812 CM272 DNA Methyltransferase Epigenetics CM-272 is a novel first-in-class dual reversible inhibitor of G9a (GLP) and DNMTs with IC50 of 8?nM, 382 nM, 85 nM, 1200 nM, 2?nM for G9a, DNMT1, DNMT3A, DNMT3B, GLP, respectively. CM-272 prolongs survival in in vivo models of haematological malignancies by at least in part inducing immunogenic cell death.
      S9729 Visomitin (SKQ1) Others Others INT-777 (S-EMCA) is a novel potent and selective TGR5 agonist with EC50 values of 0.18 μM, 3.9 μM and 1.45 μM for WT TGR5, TGR5(N76A) and TGR5(Y89F) respectively.
      S8500 BAY1125976 Akt PI3K/Akt/mTOR BAY 1125976 is a selective allosteric AKT1/2 inhibitor,exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models. BAY1125976 inhibits the activity of AKT1 (IC50?=?5.2 nM at 10 μM ATP and 44 nM at 2 mM ATP) and AKT2 (IC50?=?18 nM at 10 μM ATP and 36 nM at 2 mM ATP) very potently.Whereas BAY1125976 is almost inactive on AKT3 (IC50?=?427 nM at 10 μM ATP).
      點擊更多
      精品国产丝袜黑色高跟鞋_白嫩在线播放_国产手机在线ΑⅤ片无码观看_动漫网站黄